Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
MC2 Therapeutics
MC2 Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Wynzora
Betamethasone
,
Calcipotriene
2020-07-20
2027-2039
Psoriasis
,
Atopic dermatitis
,
Pruritus ani
,
Inflammation
,
Facial dermatoses
,
Seborrheic dermatitis
,
Foot dermatoses
,
Hand dermatoses
,
Scalp dermatoses
,
Leg dermatoses
,
Mycoses
,
Oral candidiasis
,
Vulvovaginal candidiasis
,
Tinea pedis
,
Cutaneous candidiasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Betamethasone
vasoconstriction
,
photoallergic dermatitis
,
phototoxic dermatitis
,
psoriasis
Calcipotriene
vasoconstriction
,
photoallergic dermatitis
,
phototoxic dermatitis
,
psoriasis
Microcrystalline cellulose
macular edema
,
retinal diseases
,
diabetic retinopathy
,
otitis
,
otitis externa
,
uveitis
,
anterior uveitis
,
iridocyclitis
,
inflammation
,
cataract
,
edema
,
corneal edema
Corticoids
myelodysplastic syndromes
,
thrombocytopenia
,
aplastic anemia
,
preleukemia
,
pancytopenia
,
bone marrow failure disorders
,
cytopenia
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
systemic lupus erythematosus
,
respiratory tract diseases
,
immune system diseases
,
lung diseases
,
inflammation
,
bronchial diseases
,
obstructive lung diseases
,
hypersensitivity
,
immediate hypersensitivity
,
respiratory hypersensitivity
,
kidney transplantation
,
graft rejection
,
atopic dermatitis
,
eczema
,
dermatitis
,
asthma
,
psoriasis
,
multiple myeloma
,
plasma cell neoplasms
,
colorectal neoplasms
,
neoplasm metastasis
Daivonex
alopecia areata
,
vitiligo
,
localized scleroderma
,
vasoconstriction
,
photoallergic dermatitis
,
phototoxic dermatitis
,
healthy volunteers/patients
,
squamous cell neoplasms
,
systemic scleroderma
,
alopecia
,
breast neoplasms
,
skin neoplasms
,
immunotherapy
,
organ transplantation
,
drug-related side effects and adverse reactions
,
mesenchymal stem cell transplantation
,
dermatitis
,
eczema
,
arthritis
,
pruritus
,
radiodermatitis
,
atopic dermatitis
,
squamous cell carcinoma
,
carcinoma
,
basal cell carcinoma
,
carcinoma in situ
,
psoriasis
,
actinic keratosis
,
keratosis
,
connective tissue diseases
,
skin and connective tissue diseases
,
inflammation
,
acne vulgaris
,
skin diseases
,
coronary artery disease
,
myocardial ischemia
,
atherosclerosis
,
erythema multiforme
,
papulosquamous skin diseases
,
contact dermatitis
,
graft vs host disease
,
exanthema
,
topical administration
,
allergic contact dermatitis
,
insulin resistance
,
blood coagulation disorders
,
blood platelet disorders
,
hemostatic disorders
,
coagulation protein disorders
,
oral lichen planus
,
lichen planus
,
warts
Diprosone
vasoconstriction
,
photoallergic dermatitis
,
phototoxic dermatitis
,
psoriasis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use